Global Gene Therapy On Cardiovascular Disease Market Research Report 2024(Status and Outlook)

Global Gene Therapy On Cardiovascular Disease Market Research Report 2024(Status and Outlook)



Report Overview:

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential treatment option for acquired and inherited cardiovascular diseases that remain with unmet clinical needs.

The Global Gene Therapy On Cardiovascular Disease Market Size was estimated at USD 177.37 million in 2023 and is projected to reach USD 8611.65 million by 2029, exhibiting a CAGR of 91.00% during the forecast period.

This report provides a deep insight into the global Gene Therapy On Cardiovascular Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy On Cardiovascular Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy On Cardiovascular Disease market in any manner.

Global Gene Therapy On Cardiovascular Disease Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Biogen

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen

Spark Therapeutics

Akcea Therapeutics

bluebird bio

Sunway Biotech

SIBIONO

AnGes

Orchard Therapeutics

Human Stem Cells Institute

Market Segmentation (by Type)

Viral Gene Therapy

Non-Viral Gene Therapy

Market Segmentation (by Application)

Heart Disease

Vascular Disease

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Gene Therapy On Cardiovascular Disease Market
  • Overview of the regional outlook of the Gene Therapy On Cardiovascular Disease Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy On Cardiovascular Disease Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Therapy On Cardiovascular Disease
1.2 Key Market Segments
1.2.1 Gene Therapy On Cardiovascular Disease Segment by Type
1.2.2 Gene Therapy On Cardiovascular Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene Therapy On Cardiovascular Disease Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene Therapy On Cardiovascular Disease Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene Therapy On Cardiovascular Disease Market Competitive Landscape
3.1 Global Gene Therapy On Cardiovascular Disease Sales by Manufacturers (2019-2024)
3.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy On Cardiovascular Disease Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene Therapy On Cardiovascular Disease Sales Sites, Area Served, Product Type
3.6 Gene Therapy On Cardiovascular Disease Market Competitive Situation and Trends
3.6.1 Gene Therapy On Cardiovascular Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy On Cardiovascular Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene Therapy On Cardiovascular Disease Industry Chain Analysis
4.1 Gene Therapy On Cardiovascular Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Therapy On Cardiovascular Disease Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene Therapy On Cardiovascular Disease Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2019-2024)
6.3 Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
6.4 Global Gene Therapy On Cardiovascular Disease Price by Type (2019-2024)
7 Gene Therapy On Cardiovascular Disease Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy On Cardiovascular Disease Market Sales by Application (2019-2024)
7.3 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) by Application (2019-2024)
7.4 Global Gene Therapy On Cardiovascular Disease Sales Growth Rate by Application (2019-2024)
8 Gene Therapy On Cardiovascular Disease Market Segmentation by Region
8.1 Global Gene Therapy On Cardiovascular Disease Sales by Region
8.1.1 Global Gene Therapy On Cardiovascular Disease Sales by Region
8.1.2 Global Gene Therapy On Cardiovascular Disease Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy On Cardiovascular Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy On Cardiovascular Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy On Cardiovascular Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy On Cardiovascular Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy On Cardiovascular Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biogen
9.1.1 Biogen Gene Therapy On Cardiovascular Disease Basic Information
9.1.2 Biogen Gene Therapy On Cardiovascular Disease Product Overview
9.1.3 Biogen Gene Therapy On Cardiovascular Disease Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Gene Therapy On Cardiovascular Disease SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Gene Therapy On Cardiovascular Disease Basic Information
9.2.2 Novartis Gene Therapy On Cardiovascular Disease Product Overview
9.2.3 Novartis Gene Therapy On Cardiovascular Disease Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Gene Therapy On Cardiovascular Disease SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Gene Therapy On Cardiovascular Disease Basic Information
9.3.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Overview
9.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Market Performance
9.3.4 Gilead Sciences Gene Therapy On Cardiovascular Disease SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Sarepta Therapeutics
9.4.1 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Basic Information
9.4.2 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
9.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
9.4.4 Sarepta Therapeutics Business Overview
9.4.5 Sarepta Therapeutics Recent Developments
9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Basic Information
9.5.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Overview
9.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Market Performance
9.5.4 Alnylam Pharmaceuticals Business Overview
9.5.5 Alnylam Pharmaceuticals Recent Developments
9.6 Amgen
9.6.1 Amgen Gene Therapy On Cardiovascular Disease Basic Information
9.6.2 Amgen Gene Therapy On Cardiovascular Disease Product Overview
9.6.3 Amgen Gene Therapy On Cardiovascular Disease Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Gene Therapy On Cardiovascular Disease Basic Information
9.7.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
9.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Akcea Therapeutics
9.8.1 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Basic Information
9.8.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
9.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
9.8.4 Akcea Therapeutics Business Overview
9.8.5 Akcea Therapeutics Recent Developments
9.9 bluebird bio
9.9.1 bluebird bio Gene Therapy On Cardiovascular Disease Basic Information
9.9.2 bluebird bio Gene Therapy On Cardiovascular Disease Product Overview
9.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Product Market Performance
9.9.4 bluebird bio Business Overview
9.9.5 bluebird bio Recent Developments
9.10 Sunway Biotech
9.10.1 Sunway Biotech Gene Therapy On Cardiovascular Disease Basic Information
9.10.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Overview
9.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Market Performance
9.10.4 Sunway Biotech Business Overview
9.10.5 Sunway Biotech Recent Developments
9.11 SIBIONO
9.11.1 SIBIONO Gene Therapy On Cardiovascular Disease Basic Information
9.11.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Overview
9.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Product Market Performance
9.11.4 SIBIONO Business Overview
9.11.5 SIBIONO Recent Developments
9.12 AnGes
9.12.1 AnGes Gene Therapy On Cardiovascular Disease Basic Information
9.12.2 AnGes Gene Therapy On Cardiovascular Disease Product Overview
9.12.3 AnGes Gene Therapy On Cardiovascular Disease Product Market Performance
9.12.4 AnGes Business Overview
9.12.5 AnGes Recent Developments
9.13 Orchard Therapeutics
9.13.1 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Basic Information
9.13.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
9.13.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
9.13.4 Orchard Therapeutics Business Overview
9.13.5 Orchard Therapeutics Recent Developments
9.14 Human Stem Cells Institute
9.14.1 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Basic Information
9.14.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Overview
9.14.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Market Performance
9.14.4 Human Stem Cells Institute Business Overview
9.14.5 Human Stem Cells Institute Recent Developments
10 Gene Therapy On Cardiovascular Disease Market Forecast by Region
10.1 Global Gene Therapy On Cardiovascular Disease Market Size Forecast
10.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Therapy On Cardiovascular Disease Market Size Forecast by Country
10.2.3 Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Forecast by Region
10.2.4 South America Gene Therapy On Cardiovascular Disease Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy On Cardiovascular Disease by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gene Therapy On Cardiovascular Disease Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene Therapy On Cardiovascular Disease by Type (2025-2030)
11.1.2 Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene Therapy On Cardiovascular Disease by Type (2025-2030)
11.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Application (2025-2030)
11.2.1 Global Gene Therapy On Cardiovascular Disease Sales (K Units) Forecast by Application
11.2.2 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings